Sodium phosphate (oral)
Generic name
Sodium phosphate (oral)
Brand name
ATC Code
A12CX
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Hypophosphataemia |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Caution is needed in young children.
When phosphate is supplemented in children, sodium dihydrogen phosphate is preferred instead of disodium dihydrogen phosphate and/or potassium salts in order to keep the sodium and potassium exposure as low as possible
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
MINERAL SUPPLEMENTS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| CALCIUM | ||
|---|---|---|
| A12AA04 | ||
| A12AX | ||
| A12AA06 | ||
| POTASSIUM | ||
|---|---|---|
| A12BA30 | ||
| A12BA01 | ||
| A12BA02 | ||
| OTHER MINERAL SUPPLEMENTS | ||
|---|---|---|
| A12CC05 | ||
| A12CC01 | ||
| A12CC04 | ||
| A12CC03 | ||
| A12CC02 | ||
| A12CE02 | ||
| A12CA01 | ||
| A12CB01 | ||
References
- Latta K et al., Therapeutics of X-linked hypophosphatemic rickets., Pediatr Nephrol., 1993, Dec;7(6):, 744-8
- UMC St. Radboud.., Indicatiegericht formularium, Versie 1.1.1.0. ., Geraadpleegd: feb 2014, http://igf.medecs.nl/Default.aspx?locatie=Umcn
Changes
Therapeutic Drug Monitoring
Overdose
